Old Saying About Prostate Cancer Not True When It’s Metastatic
Nearly 80% of men with metastatic prostate cancer died from their malignancy, according to a retrospective cohort study involving 26,000-plus American men... Read More
Nearly 80% of men with metastatic prostate cancer died from their malignancy, according to a retrospective cohort study involving 26,000-plus American men... Read More
Could imaging be used for routine screening for prostate cancer in healthy men — similar to mammography for breast cancer screening? A quick scan —... Read More
WebMD Chief Medical Officer John Whyte talks with Dr Arturo Holmes II about why he wears his physician scrubs out in public. Watch... Read More
The MEAL study was a prospective, randomized [phase 3] clinical trial to assess whether or not a dietary intervention prevents... Read More
High-volume referral centers throughout the United States are seeing a consistent decrease in low-grade prostate cancer and an absolute increase... Read More
Many clinicians who treat men with prostate cancer may be unfamiliar with the term “treatment-emergent small-cell neuroendocrine prostate cancer” (t-SCNC).... Read More
Two systemic drugs for the treatment of newly diagnosed metastatic prostate cancer, docetaxel (Taxotere, Pfizer) and abiraterone acetate (Zytiga, Janssen),... Read More
Addressing a packed hall at the American Society of Clinical Oncology (ASCO) 2018 annual meeting, the president of ASCO drew... Read More
In 2012, the US Preventive Services Task Force recommended against routine prostate cancer screening of asymptomatic men to detect early... Read More
Can diet modification reduce prostate cancer progression in men undergoing active surveillance? An ongoing study is slated to answer just... Read More